IDSA warns: New antibiotics needed ASAP

Nov 8, 2004

Once referred to as "miracle drugs" for their ability to eradicate infection and save countless lives, antibiotics are losing their battle against resistant organisms, and no fresh supply of novel drugs exists. Unless antibiotic research and development is reinvigorated soon, a public health crisis is imminent.

Gray Areas Exist in Proper Precision Medicine Application in Oncology

March 31st 2023

Reach Your Business Goals in 2021

March 25th 2021

FDA Approves Expanded Indication for Adjuvant Abemaciclib in HR+/HER2- Early Breast Cancer

March 8th 2023

ThoughtSpot Series: Closing the Healthcare Gap

January 7th 2021

FDA Clears First Commercially Available Blood Test to Evaluate for TBI, Concussion

March 7th 2023

The High Cost of Improper Cost Cutting: How Focusing on Pharmacy Can Add to a Hospital’s Bottom Line

March 7th 2023

Gray Areas Exist in Proper Precision Medicine Application in Oncology

March 31st 2023

Reach Your Business Goals in 2021

March 25th 2021

FDA Approves Expanded Indication for Adjuvant Abemaciclib in HR+/HER2- Early Breast Cancer

March 8th 2023

ThoughtSpot Series: Closing the Healthcare Gap

January 7th 2021

FDA Clears First Commercially Available Blood Test to Evaluate for TBI, Concussion

March 7th 2023

The High Cost of Improper Cost Cutting: How Focusing on Pharmacy Can Add to a Hospital’s Bottom Line

March 7th 2023

Gray Areas Exist in Proper Precision Medicine Application in Oncology

March 31st 2023

Reach Your Business Goals in 2021

March 25th 2021

FDA Approves Expanded Indication for Adjuvant Abemaciclib in HR+/HER2- Early Breast Cancer

March 8th 2023

ThoughtSpot Series: Closing the Healthcare Gap

January 7th 2021

FDA Clears First Commercially Available Blood Test to Evaluate for TBI, Concussion

March 7th 2023

The High Cost of Improper Cost Cutting: How Focusing on Pharmacy Can Add to a Hospital’s Bottom Line

March 7th 2023

Related Content

Gray Areas Exist in Proper Precision Medicine Application in Oncology

March 31st 2023

Article

Precision oncology is a growing, changing field.

Reach Your Business Goals in 2021

March 25th 2021

Podcast

In part 1 of our podcast series with American Associated Pharmacies (AAP), AAP President and CEO Jon Copeland dives into key pharmacy industry trends.

FDA Approves Expanded Indication for Adjuvant Abemaciclib in HR+/HER2- Early Breast Cancer

March 8th 2023

Article

The expansion was based on 4-year data from the monarchE study.

ThoughtSpot Series: Closing the Healthcare Gap

January 7th 2021

Podcast

Our final episode in our ThoughtSpot 2020 podcast series features NPhA president Dr. Ryan Marable and immediate past president Dr. Lakesha Butler, who share insights on health disparities and the social determinants of health.